Wirtschaftsnachrichten (Symbolbild).
Dienstag, 16.03.2021 19:05 von | Aufrufe: 108

INVESTIGATION ALERT: Halper Sadeh LLP Investigates STAY, GNMK, RMBL, FI, NTEC; Shareholders are Encouraged to Contact the Firm

Wirtschaftsnachrichten (Symbolbild). pixabay.com

PR Newswire

NEW YORK, March 16, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

Extended Stay America, Inc. (NASDAQ: STAY) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to a joint venture between funds managed by Blackstone Real Estate Partners and Starwood Capital Group for $19.50 per share in cash. If you are an Extended Stay shareholder, click here to learn more about your rights and options.

GenMark Diagnostics, Inc. (NASDAQ: GNMK) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Roche for $24.05 per share in cash. If you are a GenMark shareholder, click here to learn more about your rights and options

RumbleOn, Inc. (NASDAQ: RMBL) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with RideNow. If you are a RumbleOn shareholder, click here to learn more about your rights and options.

Frank's International N.V. (NYSE: FI) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Expro Group. If you are a Frank's shareholder, click here to learn more about your rights and options.

Intec Pharma Ltd. (NASDAQ: NTEC) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Decoy Biosystems, Inc. Upon completion of the merger, former Decoy stockholders are expected to own approximately 75% of the combined company, and Intec shareholders are expected to own approximately 25% of the combined company, on a fully diluted basis. If you are an Intec shareholder, click here to learn more about your rights and options.


ARIVA.DE Börsen-Geflüster

Kurse

GenMark Diagnostics Chart
-  
0,00%
Intec Pharma Chart
5,42 $
0,00%
RumbleON Chart

Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com 


 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/investigation-alert-halper-sadeh-llp-investigates-stay-gnmk-rmbl-fi-ntec-shareholders-are-encouraged-to-contact-the-firm-301248677.html

SOURCE Halper Sadeh LLP

Werbung

Mehr Nachrichten zur GenMark Diagnostics Aktie kostenlos abonnieren

E-Mail-Adresse
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.


Andere Nutzer interessierten sich auch für folgende News